5 min read
Highlights from the December 2022 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired
Tag : Egfr
5 min read
4 min read
Is Metformin Now in Our Armamentarium for Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Orhan Efe @OrhanEfe_ Dr. Orhan Efe is a Nephrologist at Massachusetts General Hospital in Boston, MA. Dr. Efe was an AJKD Editorial Intern from
7 min read
Highlights from the June 2022 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired
3 min read
Can We Predict the Risk of CKD Progression Based on Routinely Available Laboratory Tests?
Chronic kidney disease (CKD) is a significant public health issue that affects more than 37 million individuals in the United States. Due to its
5 min read
Race Multiplier in the eGFR Equation: What’s the impact for African-Americans?
Background: Race is a sociological construct that affects how clinicians deliver health care to various racial/ethnic groups. This in turn affects
7 min read
Highlights from the May 2022 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired
7 min read
Highlights from the May 2022 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired
2 min read
NHS grants fast-track access to Takeda’s lung cancer drug Exkivity
Takeda has secured UK approval its lung cancer therapy Exkivity, with an NHS access deal that could see it being prescribed to patients within the
On Arguments of Race and Estimated GFR
Update: The Final Report was published on September 23, 2021. A Special Report published in AJKD highlights an interim report from the joint NKF/ASN
1 min read
Primary FSGS: Using Proteinuria as an Endpoint
Focal segmental glomerulosclerosis (FSGS) is a histologic description with numerous etiologies and proposed pathogenic mechanisms. Proteinuria,
5 min read
The Rise of the LVAD and the Fall of the eGFR: A Commentary on LVAD Patients Receiving Maintenance Dialysis and Rivalry
The 1960s in the United States was a roller-coaster of a decade characterized by protests for the civil rights movement, the war in Vietnam,
1 min read
Non-Small Cell Lung Cancer Drug Development Summit
The Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit is the definitive industry-led forum for drug development in the largest solid
Guardant360® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers
REDWOOD CITY, Calif.–(BUSINESS WIRE)– Guardant Health, Inc. (Nasdaq: GH) has CE-marked Guardant360® CDx for tumor mutation profiling, also
2 min read
Trial Will Test AFM24-Tecentriq Combo for EGFR-positive Advanced Cancers
Affimed will team up with Roche to conduct a Phase 1/2a clinical trial investigating its innate cell engager AFM24 — a form of immunotherapy — in
4 min read
Can Histopathology Assist in Predicting the Time of Kidney Failure?! What’s New!
Predicting progression is one of the most important and challenging jobs for a nephrologist. Current estimation in clinical practice is based on